Design of Biologically Safer Chemicals Based on Retrometabolic Concepts

ACS Symposium Series

Volumn 640, Issue , 1996, Pages 84-115

  Bodor, Nicholas ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1542680933     PISSN: 00976156     EISSN: None     Source Type: Book Series    
DOI: 10.1021/bk-1996-0640.ch005     Document Type: Article

References (34)

1. Bodor, N.; Kaminski, J. J. Med. Chem. 1980, 23, 469-474.
2. Bodor, N.; Kaminski, J. J. Med. Chem. 1980, 23, 566-569.
3. Bodor, N.; Wood, R.; Raper, C.; Kearney, P.; Kaminski, J. J. Med. Chem. 1980, 23, 474-480.
4. Mannering, G.J., In Concepts in Drug Metabolism; Jenner, P.; Testa, B., Eds.; Marcel Dekker, Inc: New York, 1981.
5. Bodor, N. In Strategy in Drug Research; Buisman, J.A.K., Ed.; Elsevier Scientific Publishing Company: Amsterdam, 1982.
6. Bodor, N. Chemtech 1984, 28-38.
7. Bodor, N.; Brewster, M.E. Pharm. Therapy 1981, 19, 337-386.
8. Bodor, N.; Prokai, L.; Wu, W.; Farag, H.; Jonnalagadda, S.; Kawamura, M.; Simpkins, J. Science 1992, 257, 1698-1700.
9. Bodor, N. In Trends in Medicinal Chemistry 90; Sarel, S.; Mechoulam, R.; Agranat, I., Eds.; Blackwell Scientific Publications: 1992; pp 35-44.
10. Bodor, N. Med. Res. Reviews 1984, 3(4), 449-469.
11. Bodor, N.; Oshiro, Y.; Loftsson, T.; Katovich, M.; Caldwell, W. Pharm Res. 1984, 3, 120-125.
12. Bodor, N.; Sloan K.; Little, R.; Selk, S.; Caldwell, L. Int. J. Pharm. 1982, 10, 307-321.
13. Bodor, N.; Sloan, K. J. Pharm. Sci. 1982, 71(5), 514-520.
14. Bodor, N. In Topical Corticosteroid Therapy: A Novel Approach to Safer Drugs; Christopers, E., et al., Eds.; Raven Press Ltd.: New York, 1988.
15. Bodor, N.; El-Koussi, A.; Kano, M.; Khalifa, M. J. Med. Chem. 1988, 31, 1651-1656.
16. Hammer, R.; Amin, K.; Gunes, Z.; Brouillette, G.; Bodor, N. Drug Des. & Del. 1988, 2, 207-219.
17. Bodor, N. In Enc. of Human Biol.: Academic Press: San Diego, 1991.
18. Bodor, N. In Topical Glucocorticoids with Increased Benefit-Risk Ratio; Korting, H., Ed.: A. G. Karger: Basel, 1993.
19. Bodor, N. and El-Koussi, A. Cur. Eye Res. 1988, 7(4), 369-374.
20. Bodor, N.; Gabanyi, Z.; Wong, C. J. Am. Chem. Soc. 1989, 111, 3783-3787.
21. Kaminski, J.; Bodor, N.; Higuchi, T. J. Pharm. Sci. 1976, 65, 553-557.
22. Kaminski, J.; Bodor, N.; Higuchi, T. J. Pharm. Sci. 1976, 65, 1733-1737.
23. Kaminski, J. Huycke, M.; Selk, S.; Bodor, N.; Higuchi, T. J. Pharm. Sci. 1976, 65, 1737-1742.
24. Francis, R.J.; East, P.B.; McLaren, S.J.; Harman, J. Biomed. Mass. Spectrom. 1976, 3, 281-285.
25. EPO Pat. 386901/Dec. 12, 1990 by ONO Pharmaceutical Co., Japan.
26. Druzgala, P.; Hochhaus, G.; Bodor, N. J. Steroid Biochem. 1991, 38(2), 149-154.
27. Druzgala, P.; Bodor, N. Steroids 1991, 56, 490-494.
28. Bodor, N.; Oshiro, Y.; Loftsson, T.; Katovich, M.; Caldwell, W. Pharm. Res. 1984, 3, 120-125.
29. Bodor, N.; Elkoussi, A.; Kano, M.; Khalifa, M. J. Med. Chem. 1988, 31, 1651-1656.
30. Yang, H.; Wu, W.; and Bodor, N. Pharm. Res. 1995, 12(3), 329-336.
31. Bodor, N.; Gabanyi, Z.; Wong, C. J. Am. Chem. Soc. 1989, 111, 3783-3786.
32. Bodor, N.; Huang, M. J. Pharm. Sci. 1992, 81(3), 272-281.
33. Bodor, N.; Harget, A.; Huang, M. J. Am. Chem. Soc. 1991, 113, 9480-9483.
34. Bodor, N.; Huang, M. In Computer-Aided Molecular Design; Reynolds, C.H.; Holloway, M.K.; Cox, H.K., Eds.; ACS Symposium Series 589; American Chemical Society: Washington, DC, 1994; pp. 98-113.